Business Giants Make Billion-Dollar Movesby Mark Eisenberg 12.02.2024Mondi is considering a possible takeover of DS Smith, a move that could have significant implications for the packaging industry. ...
Cooper Standard: Insider Promoted Amid CFO Shuffleby Terry Bingman 12.02.2024Cooper Standard promotes Alison Nudd to Vice President and Chief Accounting Officer, strengthening financial operations for future success.
Gilead’s $4.3B Bet on CymaBay’s Liver Drugby Mark Eisenberg 12.02.2024Gilead Sciences plans to acquire CymaBay Therapeutics for $4.3 billion, expanding their liver disease portfolio. The deal is expected to ...
Unlock Tax-Free Income: Federated Hermes’ Latest Dividendby Mark Eisenberg 12.02.2024Federated Hermes Premier Municipal Income Fund declares tax-free dividend distribution, solidifying its position as a reliable investment partner and attracting ...
Lowe’s Stock Surges as Fed Eyes Rate Cutsby Mark Eisenberg 12.02.2024Lowe's stock could gain from potential Federal Reserve rate cuts, according to J.P. Morgan. The bank upgraded its rating and ...
Arthur J. Gallagher & Co. Expands Global Reachby Mark Eisenberg 12.02.2024Arthur J. Gallagher & Co. expands its global reach with the acquisition of Simply-Communicate Ltd, aiming to strengthen its capabilities ...
Intuitive Machines: Stock Surge Ahead of Lunar Questby Lilu Anderson 12.02.2024Intuitive Machines' stock soars as it prepares for a historic moon mission. A successful landing would be a major achievement ...
FTC Solar: Will Behnen’s CFO Appointment Lead to Turnaround?by Terry Bingman 12.02.2024FTC Solar has named Cathy Behnen as its CFO, bringing two decades of financial leadership experience to the role. Behnen's ...
Kratos Secures $877M Space Defense Contractby Lilu Anderson 12.02.2024Kratos Defense & Security Solutions secures a $877 million contract for its Space & Missile Defense Systems unit, bolstering its ...
NRx Pharmaceuticals: $5M Boost for NRX-101 Drugby Mark Eisenberg 12.02.2024NRx Pharmaceuticals receives a $5 million milestone payment for the development of its drug candidate NRX-101, supporting its progress through ...